How Much Did Dexcare Raise?
Funding & Key Investors

Dexcare, a prominent player in the healthcare intelligence sector, has successfully secured a major strategic investment to further its mission of optimizing patient access and health system capacity. This latest capital injection, totaling $75M, underscores the market's confidence in the company's ability to modernize the digital front door for large-scale medical providers. With a cumulative backing of $75M, Dexcare is well-positioned to accelerate its enterprise-level growth strategy and expand its footprint across the United States healthcare landscape.

The recent financing round reflects a broader trend of institutional interest in platforms that bridge the gap between consumer demand and clinical resource allocation. By leveraging its unique position as a spin-out from Providence, Dexcare continues to attract high-caliber partners who recognize the critical need for data-driven orchestration in an increasingly complex medical environment.

What is Dexcare?

Dexcare
SoftwareHealthcare Software

Dexcare operates as a sophisticated intelligence platform designed to orchestrate digital demand and health system capacity. By integrating seamlessly with existing Electronic Medical Record (EMR) systems, the company provides a unified digital experience that attracts commercially-insured consumers while maximizing operational efficiency. The platform's core value proposition lies in its intelligent navigation engine, which dynamically allocates resources across various providers, service lines, and care modalities. This capability allows health systems to flex their operations in real-time, meeting both consumer expectations for convenience and the business objectives of the provider organization. Currently serving major health systems such as Kaiser Permanente and Mass General Brigham, Dexcare has demonstrated significant impact, including increased patient acquisition and substantial cost savings per encounter.

How much funding has Dexcare raised?

Dexcare has raised a total of $75M across 1 funding round:

2023

Series C

$75M

Series C (2023): $75M with participation from Kaiser Permanente, Transformation Capital, and ICONIQ Growth

Key Investors in Dexcare

Kaiser Permanente

A leading not-for-profit healthcare organization providing integrated medical services through an extensive network of hospitals and clinics, known for its commitment to technological advancement in care delivery.

Transformation Capital

A Boston-based growth equity fund that specializes exclusively in supporting innovative healthcare IT and services companies.

ICONIQ Growth

A strategic investment firm that partners with visionary entrepreneurs to drive global impact, leveraging a vast ecosystem of industry leaders to support companies from early growth stages to IPO.

What's next for Dexcare?

Looking ahead, the infusion of capital will likely be directed toward scaling the platform's technical infrastructure and expanding its reach into new health systems. As the healthcare industry continues to prioritize digital transformation, Dexcare's focus on load balancing and resource optimization remains a critical differentiator. The company is expected to deepen its integration capabilities, further amplifying the value of existing caregiver and brand investments for its partners. By maintaining its commitment to data-driven intelligence, Dexcare is poised to remain a central component of the modern health system's digital strategy, potentially setting the stage for further market penetration and long-term operational sustainability.

See full Dexcare company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Engineering SoftwareSoftware
Financial SoftwareSoftwareFinanceSecurities Trading
Engineering SoftwareSoftware
Content & Collaboration SoftwareSoftwareEducationTraining

Frequently Asked Questions Regarding Dexcare Financial Insights

What are the most recent funding rounds that Dexcare has completed, and what were the funding rounds?
Dexcare has recently completed 1 funding rounds: Series C on Jun 21, 2023.
What is the total amount of funding Dexcare has raised to date?
Dexcare has raised a total of $75M in funding to date.
How many funding rounds has Dexcare completed?
Dexcare has completed 1 funding rounds.
How much funding did Dexcare raise in its most recent funding round?
Dexcare raised $75M in its most recent funding round.
Who are the lead investors in Dexcare's latest funding round?
The lead investor in Dexcare's latest funding round was Kaiser Permanente. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Dexcare's history?
The largest funding round in Dexcare's history was $75M.
See more information about Dexcare